Troy Lund, MD, PhD

Dr. Lund is interested in the use of hematopoietic stem cell transplantation (HSCT) primarily for patients with inherited metabolic disorders, like Adrenoleukodystrophy (ALD), Hurler syndrome (MPS-1H), Hunter syndrome, Metachromatic Leukodystrophy, and others. He studies the onset of disease, biomarkers of disease, mechanism of disease, and how HSCT improves the disease process. His work both in his research laboratory and with his patients has created many new approaches to treatment, which will ultimately make HSCT safer and more effective.

"Yes, we’re saving lives. But that’s not enough. I want to improve the quality of life for these kids, and that’s where I’m focusing my energy.”

• Minneapolis - St. Paul Magazine "Top Doctor" (2020, 2021)
• Team Science Award, Department of Pediatrics, University of Minnesota (2019)
• Basic Science Paper of the Year (Assistant Professor), Department of Pediatrics, University of Minnesota (2015)
• Butterfly Award for Outstanding Medical Research, Children’s Cancer Research Fund (2014)
• 1st Place Outstanding Achievement in Research by Fellow/Margaret Kendrick Hostetter Award (2007,2009)
• AAP International Travel Award to establish G6PD testing in Kampala, Uganda (2006)
• International Medical Education Resource Scholarship to present an abstract at the International Health Medical Education Consortium meeting in Havana, Cuba (2002)
• Department of Medicine Research Day - Best Medical Student Poster (2002)
• International Travel Award from China Board of New York - to attend Human Rights and Research - An International Perspective conference in Kunming, China (2001)
• Medical Research Council Laboratory, The Gambia, West Africa developed a PCR protocol to detect HIV-1/HIV-2 from dried blood spots collected in the field (2001)
• Spink International Scholarship (2001)
• International Graduate & Professional Scholarship (2001)
• Dr. Garth Englund Scholarship MMF Verndon D.E. Scholarship (2000)
• PhD with "Distinction" (Top 5%) (1996)

Dr. Lund's research focuses improving the outcomes for all patients undergoing blood and marrow transplantation by increasing the speed at which hematopoietic stem cells reconstitute the immune system after transplant. He also works to increase our understanding the pathophysiological processes underlying inherited metabolic diseases. One area Dr. Lund is exploring is how an autoimmune reaction may trigger the cerebral form of adrenoleukodystrophy (cALD), the most serious form of ALD. This study represents the largest screening for immune-reactivity in cALD ever performed, and further research could help identify ALD patients with immune-reactivity prior to the onset of cALD.

Click here to see a complete list of Dr. Lund’s studies which have been published by academic and research journals.